Heart Disease Clinical Trials in Cleveland

Showing 401-420 of 448 trials

Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

NCT00079586

The purpose of this study is to demonstrate that in patients undergoing coronary artery bypass grafting (CABG) or CABG-Valve, or Isolated Cardiac Valve surgery on CPB (cardiac surgery), Angiomax is a safe and effective alternative anticoagulant to heparin with protamine reversal.

Cardiovascular DiseaseCoronary Artery Bypass Surgery

The Medicines Company150 participantsStarted Apr 2004

Cleveland, Ohio, United States

COMPLETEDPhase 3< 1 mile

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

NCT00079508

The purpose of this study is to demonstrate that in patients with heparin-induced thrombocytopenia (HIT)/heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) Type II undergoing cardiac surgery on cardiopulmonary bypass (CPB), Angiomax is a safe and effective anticoagulant.

Cardiovascular DiseaseCoronary Artery Bypass Surgery

The Medicines Company125 participantsStarted Apr 2004

Cleveland, Ohio, United States

COMPLETED< 1 mile

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

NCT00180466

PROSPECT is a multi-center prospective registry of Acute Coronary Syndromes (ACS) patients with single or double vessel coronary artery disease. Approximately 700 patients with ACS will be enrolled into the study at sites in the United States and European Union.

Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis

Abbott Medical Devices697 participantsStarted Oct 2004

Phoenix, Arizona, United States • San Jose, California, United States • Stanford, California, United States +37 more locations

Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Heart Disease Trials in Other Cities

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

The Epidemiology of Ventricular Assist Device-Related Infections

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks

Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Other Conditions in Cleveland